TRACY NICHTER: Open Payments
NPI 1770025546 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 127 payments from 32 companies in 2025. Trend: 2023 $2,743 · 2024 $2,949 · 2025 $2,493
Food & beverage: $2,438Education: $55
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $311 |
| Alexion Pharmaceuticals, Inc. | 9 | $209 |
| MDD US Operations, LLC | 11 | $192 |
| Janssen Biotech, Inc. | 9 | $160 |
| ABBVIE INC. | 8 | $158 |
| Lundbeck LLC | 9 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Averitas Pharma Inc. | 6 | $128 |
| JAZZ PHARMACEUTICALS INC. | 4 | $122 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
Products named: ULTOMIRIS, Gocovri, Rystiggo, VYEPTI, HYQVIA, QUTENZA, WAINUA, Qelbree.
Industry payments across NY — which companies pay providers there.
